Introduction

36
Ulcerative colitis (UC) is a chronic and multifactorial inflammatory bowel disease 37 (IBD), which is mainly occurred in the rectum and colon [1] . Nevertheless UC is not life-38 threatening in itself, it has been reported that chronic recurrence of UC could increase the risk 39 of colorectal cancer, which is the third most common cancer in the world [2] . Several drugs 40 such as aminosalicylic acid drugs, immune suppressor, and hormone agents have been used to 41 treat UC. However, many people are still suffered from high recurrence rates of UC and side-4 Nuclear factor-kappa B (NF-κB), which is one of the downstream factor of MAPKs, is 57 also crucial factor for treatment of UC. It has been reported that patients with UC show strongly 58 activated NF-κB in colon tissues [9] . NF-κB is consisted of p50 and p65, which normally exist 59 in cytoplasm with inhibitor of NF-κB (IκB) [10] . By extracellular stimuli, IκB is degraded and 60 phosphorylated through ubiquitin/proteasome pathway, and then NF-κB is activated. Activated 61 NF-κB is subsequently translocated into nucleus to bind with sequence of target genes [11] .
62
Translocated NF-κB can regulate transcription of inflammation related genes, including 63 cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) [10] . COX-2, which is 64 induced by inflammatory stimuli such as arthritis, asthma and IBD, contributes to not only the 65 pain and swelling, but also converting of arachidonic acid to prostaglandin E2 (PGE2) [12] [13] [14] .
66
Another downstream target of NF-κB is iNOS, which leads vasodilation of inflammatory cells 67 easily [15] . iNOS is highly expressed in inflamed intestine mucosa and induces tissue damage 68 by generating nitric oxide (NO) [16] . Therefore, suppressing NF-κB activation through
69
MAPKs cascades is crucial for treating colitis.
70
Intestinal epithelium exhibits barrier function against luminal antigens. The intestinal 71 epithelium is composed of a single epithelial cell layer. This layer is covered by mucus, which In this study, we used rhizomes of Cnidium officinale Makino (Cinidii Rhizoma; CR).
78
Cnidium officinale Makino is extensively cultivated and it has been used as medicine in East 
Results
86
EtCR Prevents Symptoms of Colitis in DSS-induced Colitis Mice
87
To estimate whether EtCR could inhibit progression of colitis, mice were administrated 88 5% DSS containing water with or without EtCR (50 mg/kg/day) and 5-ASA (50 mg/kg/day).
89
As shown in Figure 1A , administration of DSS decreased body weight compared to control 90 group. However, administration of EtCR inhibited weight loss similarly with 5-ASA, which is 91 treatment drug of colitis. Also, the severity of colitis was presented by DAI score, which 92 concerned other factors, including bleeding and diarrhea, as well as body weight. As shown in 93 Figure 2B , DAI score of DSS group was steadily increased from day 5 to day 7. However,
94
EtCR and 5-ASA treated groups showed better DAI score compared to only DSS-treated group. 2C, blue spots were well-shown in colon tissue of control group and it was seldom seen in 117 DSS-treated group. In EtCR and 5-ASA-administrated groups, the blue stained cells were 118 increased in colon tissues ( Figure 2D ). Furthermore, the TFF3 expression was recovered in 
EtCR Regulates LPS-stimulated Cytokine and Pro-Inflammatory Mediators in in vitro
124
To confirm whether EtCR could regulate inflammatory reaction, RAW 264.7 cells were 125 used in this study. Since regulation of pro-inflammatory cytokines such as IL-1β, TNF-α and 126 IL-6 is important in inflammation related diseases [27], we investigated whether EtCR has anti-127 inflammatory effects in LPS-stimulated RAW 264.7 cells. To determine the experimental dose 128 of EtCR in RAW 264.7 cells, the cells were treated with 1, 10, and 100 μg/ml of EtCR. Since EtCR did not show significant cytotoxicity up to 100 μg/ml of EtCR ( Figure 3A) , we used 100 130 μg/ml of EtCR as a highest concentration. As shown in Figure 3B- cytokines is also crucial for colitis. As shown in Figure 4A ,B, pre-treatment of EtCR decreased 138 levels of NO and PGE2, which were elevated by LPS. In addition, we investigated expression to inflammatory responses [29] . As shown in Figure 5A ,B, IκB in the cytoplasm was 147 phosphorylated and degraded by LPS stimulation, which is an inflammatory stimulus. And 148 then, NF-κB p65 was translocated into the nucleus. However, the treatment of EtCR suppressed 149 this signaling pathway. In addition, the result of NF-κB binding assay showed that the EtCR 9 treatment effectively reduced the NF-κB binding activity, dose dependently ( Figure 5C ). It was 151 also reported that the NF-κB signaling is regulated by MAPKs, including ERK, JNK, and p38 152 [30] . As shown in Figure 5D and 
Discussion
166
UC and Crohn's disease (CD) are the two most common forms of IBD, which is 167 characterized by a chronic inflammation of intestine. The etiologies of both diseases are unclear.
168
However, main cause of these diseases is considered to multifactorial, including environmental 169 factors such as smoking and western diet, the genetic factors and the intestinal flora [32] .
170
Although the symptoms between UC and CD are similar in many parts, there are also slightly is more severe than UC, but the incidence of CD is much lower than UC [33] . In addition, the 174 treatment drugs of UC, including 5-ASA and glucocorticoids, occurred side-effects such as 175 arthralgia, myalgia, headache, and abdominal pain [34] . Therefore, our study focused on UC 176 rather than CD and suggested the new therapeutic agents of UC using natural products with 177 few side effects.
178
EtCR is expected that could improve colitis through several research findings about EtCR.
179
It has been reported that the health functional food containing CR improved TNBS-induced 180 colitis and histological changes such as thickening, dilatation, ulceration, and infiltration [35] .
181
In addition, CR had anti-inflammatory effect by reducing NO production in LPS-stimulated 
198
In our experiment, administration of DSS almost eroded epithelial layer and crypt. expressions of iNOS and COX-2 were inhibited by EtCR. In addition, the production of NO 225 and PGE2, which are produced by iNOS and COX-2, were also decreased by EtCR (Figure 4 ).
226
Thus, it is quite convincing that therapeutic effect on UC may come from anti-inflammatory 227 properties of EtCR. 
Experimental Section
Induction of DSS-induced Colitis in Mouse Model
281
Female BALB/c mice (6 weeks old) were purchased from Samtaco Science (Osan,
282
Republic of Korea). Before inducing colitis, mice were maintained in experimental 
Disease Activity Index (DAI)
297
DAI was calculated by scoring weight loss, diarrhea, and rectal bleeding. Each score was 298 assessed as shown in Table 1 
Colon Tissue Staining and Evaluation of Colitis Severity
305
All resected colon tissues were fixed in 10% neutral buffered formalin for 24 hours. After submucosa; 4. The total histological score was given as sum of epithelium and infiltration.
Alcian Blue positive cells were counted in ten random areas using microscope (Leica, Wetzlar, 
Conclusions
397
Our study demonstrated that EtCR ameliorated UC in DSS-induced mice and protected 
473
Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. 
